Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Ansell.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ‘Ansell is a buy’, while all eyes are on ImpediMed’s upcoming publication
News
Closing Bell: Energy shares push ASX higher
News
Quarterlies Top 5: Here’s another online market place that’s rising today
Experts
ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X
Health & Biotech
The ASX biotech companies that lost puff on Pfizer vaccine news
News
This professional investor is focused on resources and rare earths in a post-COVID world
News